Subacute mesenteric venous thrombosis secondary to COVID-19: A late thrombotic complication in a nonsevere patient

Alemán, Washington; Cevallos, Leonardo Cano

doi:10.1016/j.radcr.2021.01.039

Cited by 15 publications

(17 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…We also identified 30 case reports or case series [ 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 , 51 ] presenting 34 cases of acute bowel ischemia in patients positive for SARS-CoV-2 infection in different clinical settings. 8 cases were previously hospitalized for COVID-19 pneumonia and under anticoagulant medication ( Table 2 ).…”

Section: Resultsmentioning

confidence: 99%

“…Favorable results were obtained in 7 out of 9 cases (77%) of splanchnic veins thrombosis and in 2 of 7 cases (28.5%) with superior mesenteric artery thrombosis. At discharge, anticoagulation therapy was continued either with LMWH, for a period up to 3 months [ 33 , 36 , 41 ], either, long term warfarin, with INR control [ 32 , 34 , 41 ] or apixaban 5 mg/day, up to 6 months [ 26 , 47 ]. No readmissions were reported.…”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Acute Mesenteric Ischemia in COVID-19 Patients

Serban

Tribus

Vancea

et al. 2021

JCM

View full text Add to dashboard Cite

Acute mesenteric ischemia is a rare but extremely severe complication of SARS-CoV-2 infection. The present review aims to document the clinical, laboratory, and imaging findings, management, and outcomes of acute intestinal ischemia in COVID-19 patients. A comprehensive search was performed on PubMed and Web of Science with the terms “COVID-19” and “bowel ischemia” OR “intestinal ischemia” OR “mesenteric ischemia” OR “mesenteric thrombosis”. After duplication removal, a total of 36 articles were included, reporting data on a total of 89 patients, 63 being hospitalized at the moment of onset. Elevated D-dimers, leukocytosis, and C reactive protein (CRP) were present in most reported cases, and a contrast-enhanced CT exam confirms the vascular thromboembolism and offers important information about the bowel viability. There are distinct features of bowel ischemia in non-hospitalized vs. hospitalized COVID-19 patients, suggesting different pathological pathways. In ICU patients, the most frequently affected was the large bowel alone (56%) or in association with the small bowel (24%), with microvascular thrombosis. Surgery was necessary in 95.4% of cases. In the non-hospitalized group, the small bowel was involved in 80%, with splanchnic veins or arteries thromboembolism, and a favorable response to conservative anticoagulant therapy was reported in 38.4%. Mortality was 54.4% in the hospitalized group and 21.7% in the non-hospitalized group (p < 0.0001). Age over 60 years (p = 0.043) and the need for surgery (p = 0.019) were associated with the worst outcome. Understanding the mechanisms involved and risk factors may help adjust the thromboprophylaxis and fluid management in COVID-19 patients.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Acute Mesenteric Ischemia in COVID-19 Patients

Serban

Tribus

Vancea

et al. 2021

JCM

View full text Add to dashboard Cite

show abstract

“…Overall, 641 articles were screened, 21 of which were selected according to the above mentioned criteria 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 . The included articles were all case reports (except for one case series [10] ), and contained description of 21 cases.…”

Section: Resultsmentioning

confidence: 99%

Acute splanchnic vein thrombosis in patients with COVID-19: A systematic review

Buso¹,

Becchetti²,

Berzigotti³

2021

Digestive and Liver Disease

View full text Add to dashboard Cite

This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

show abstract

“…Acute mesenteric ischemia and mesenteric venous thrombosis are rare complications of COVID-19, thus, data are limited. 43 , 44 , 45 Clinicians should be vigilant for intestinal thrombotic injury in the correct context. In a case report, one patient presented with mesenteric venous thrombosis after presenting 20 days after the onset of COVID-19 with severe abdominal pain, suggesting prolonged hypercoagulability in some individuals.…”

Section: Introductionmentioning

confidence: 99%

“…In a case report, one patient presented with mesenteric venous thrombosis after presenting 20 days after the onset of COVID-19 with severe abdominal pain, suggesting prolonged hypercoagulability in some individuals. 45 …”

Section: Introductionmentioning

confidence: 99%